Fecal Immunochemical Testing (FIT) is a central tool in colorectal cancer (CRC) screening. To improve the selection of individuals for colonoscopy, risk models combining FIT with additional CRC risk f
The research cohort (COLSCREEN study) was recruited among individuals that participated during 2016-2020 in the ongoing population-based CRC screening program overseen by the Catalan Institute of Onco
The incidence risk of colorectal cancer （CRC） is increasing at 4.2% year by year in China. Most effective way to reduce the death rate of CRC patients is to diagnose in quite an early stage. QiaoKou D
